Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: IOVA stock price vs ENTG: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ENTG's multiple
Needs ENTG P/S.
Implied fair value · at IOVA's multiple
Needs IOVA P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: IOVA FY 2025 (ended Dec 31, 2025) · ENTG FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
IOVANCE BIOTHERAPEUTICS, INC. · implied price per share
Bear
-$0.65
Base
-$0.77
Bull
-$0.88
Entegris, Inc. · implied price per share
Bear
$29.61
Base
$34.83
Bull
$40.06
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.00x
0.97x
Net debt / EBITDA
Leverage against operating earnings
0.85x
3.27x
Cash and equivalents
Liquid reserves on the balance sheet
$296.98M
$362.58M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
BioNTech SE
IOVA vs BNTX
Moderna, Inc.
IOVA vs MRNA
GILEAD SCIENCES, INC.
IOVA vs GILD
Legend Biotech Corp
IOVA vs LEGN
DuPont de Nemours, Inc.
IOVA vs DD
APPLIED MATERIALS INC /DE
IOVA vs AMAT
LAM RESEARCH CORP
IOVA vs LRCX
ASML HOLDING NV
IOVA vs ASML
MKS INSTRUMENTS INC
IOVA vs MKSI
$1.00M
$3.85B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote
